GeriatricsRheumatology
Osteoporosis / Fragility Fracture
NOGG / NICE — assess fracture risk (FRAX/QFracture), DEXA, bone-protective therapy, calcium + vitamin D.
Source: NOGG 2021; NICE NG147; NG224
Step 1 of ~3
info
Assess Fracture Risk
Indications: women ≥65, men ≥75, anyone with risk factors + age ≥50 (previous fragility fracture, family hx hip fracture, BMI <19, oral steroids ≥3 months ≥7.5 mg/day, smoking, alcohol >3 units/day, falls, secondary causes).
Use FRAX (UK) or QFracture — 10-year risk of hip + major osteoporotic fracture. NOGG threshold: high → treat; intermediate → DEXA; low → lifestyle only.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Colecalciferol with calcium carbonate · Vitamin D + calcium supplement
- Risedronate with calcium carbonate and colecalciferol · Bisphosphonate + calcium/vitamin D
- Ergocalciferol with calcium lactate and calcium phosphate · Combined calcium + vitamin D
- Dairy products · Nutritional source (calcium, protein, vitamin D)
- Denosumab · Anti-RANKL Monoclonal Antibody
- Calcium 1000mg + Colecalciferol 800 units (Calcichew D3 Forte) · Calcium and Vitamin D Supplement
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5
Decision support only. Always apply local guidelines and clinical judgement.